We are live on ! Find out more
VRCA icon

Verrica Pharmaceuticals

27 hedge funds and large institutions have $164M invested in Verrica Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 27 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

31.96% more ownership

Funds ownership: 0% → 31.96% (+32%)

Holders
27
Holders Change
+27
Holders Change %
–
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

VRCA Hedge Fund Activity: Q2 2018 in Review

27 of the 4,387 institutional investors tracked by Wall St. Rank reported a position in Verrica Pharmaceuticals (VRCA) for Q2 2018, worth a combined $164M.

Buyers outnumbered sellers: 27 funds opened new VRCA positions and 0 closed out — a net gain of 27 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Perceptive Advisors, opening a new position worth an estimated $66.8M.

  • 27 institutional investors held Verrica Pharmaceuticals (VRCA) as of Q2 2018, up from 0 in Q1 2018.
  • Funds reported $164M of Verrica Pharmaceuticals stock for Q2 2018.
  • 27 funds opened new Verrica Pharmaceuticals positions in Q2 2018 and 0 closed out, a net change of +27 holders.
  • The largest Verrica Pharmaceuticals buyer in Q2 2018 was Perceptive Advisors, an estimated $66.8M added.

Based on aggregated 13F filings for Q2 2018.